Match!
Hideki Fujii
Kobe University
EndocrinologyCardiologyKidney diseaseDiabetes mellitusMedicine
135Publications
22H-index
1,849Citations
What is this?
Publications 137
Newest
#1Hideki Fujii (Kobe University)H-Index: 22
#2Keiji Kono (Kobe University)H-Index: 12
Last. Shinichi Nishi (Kobe University)H-Index: 23
view all 5 authors...
Source
#1Kohei Okamoto (Kobe University)
#2Hideki Fujii (Kobe University)H-Index: 22
Last. Shinichi Nishi (Kobe University)H-Index: 23
view all 7 authors...
Source
#1Takayuki Hamano (Nagoya City University)
#2Hideki Fujii (Kobe University)H-Index: 22
Last. Kosaku NittaH-Index: 39
view all 10 authors...
Source
#1Jun Ito (Kobe University)H-Index: 1
#2Hideki Fujii (Kobe University)H-Index: 22
Last. Shinichi Nishi (Kobe University)H-Index: 23
view all 5 authors...
We encountered a pregnant hemodialysis patient with severe hyperparathyroidism (HPT). Although her disease was considered to be refractory to medical treatment, the serum intact parathyroid hormone (PTH) level remarkably improved without manifestation of hypercalcemia through only strict serum phosphorus control, mainly via intensification of dialysis. The very strong correlation between the serum phosphorus level and serum intact PTH level suggested the possibility of secondary HPT. She ultimat...
Source
#1Kentaro Watanabe (Kobe University)H-Index: 2
Last. Nishi S
view all 5 authors...
BACKGROUND: Although mineral metabolism disorder influences cardiac valvular calcification (CVC), few previous studies have examined the effects of non-calcium-containing and calcium-containing phosphate binders on CVC in maintenance hemodialysis patients. The aim of the present study was to compare the effects of lanthanum carbonate (LC) with calcium carbonate (CC) on the progression of CVC in patients who initiated maintenance hemodialysis and to investigate clinical factors related to CVC. ME...
Source
#1Kohei Okamoto (Kobe University)
#2Hideki Fujii (Kobe University)H-Index: 22
Last. Shinichi Nishi (Kobe University)H-Index: 23
view all 6 authors...
Background Although a previous study has reported the relationship between intact parathyroid hormone (iPTH) and whole parathyroid hormone (wPTH) levels in patients undergoing dialysis, the w/i PTH ratio (whole/intact PTH ratio) among predialysis chronic kidney disease (CKD) patients remains unclear. The present study therefore aimed to examine the relationship between w/i PTH ratio and kidney function and determine other factors affecting the w/i PTH ratio.
Source
#1Hideki Fujii (Kobe University)H-Index: 22
#2Shuhei Watanabe (Kobe University)H-Index: 2
Last. Shinichi Nishi (Kobe University)H-Index: 23
view all 8 authors...
: Cardiac abnormalities, including left ventricular hypertrophy and systolic dysfunction, are frequently observed among patients with CKD, including kidney transplant recipients; they are closely linked to cardiovascular disease and mortality. Although several studies have been performed for elucidating changes and mechanisms of cardiac abnormalities after kidney transplantation, details remain unclear. This study included 43 consecutive patients who underwent HD and received kidney transplantat...
Source
#1Kimihiko Goto (Kobe University)H-Index: 1
#2Shunsuke Goto (Kobe University)H-Index: 19
Last. Shinichi Nishi (Kobe University)H-Index: 23
view all 6 authors...
Introduction Recent clinical studies demonstrated the favorable effects of calcium-free phosphate binders on mortality and vascular calcification in hemodialysis (HD) patients. The aim of the present study was to investigate the effects of a calcium-free phosphate binder, lanthanum carbonate (LC), on bone metabolic markers and bone mineral density (BMD), compared with those of calcium carbonate (CC), in subjects new to HD.
Source
#1Shuhei Watanabe (Kobe University)H-Index: 2
#2Hideki Fujii (Kobe University)H-Index: 22
Last. Shinichi Nishi (Kobe University)H-Index: 23
view all 7 authors...
Background Kidney function after acute myocardial infarction (AMI) correlates with patient prognosis. Several studies reported the role that indoxyl sulfate (IS), a uremic toxin, plays in the progression of chronic kidney disease and cardiovascular diseases. This study aims at investigating the serum IS level changes after AMI and their correlation with kidney injury.
Source
#1Hideki FujiiH-Index: 22
#2Keiji KonoH-Index: 12
view all 7 authors...
Source
12345678910